Israel Englander Moderna, Inc. Transaction History

Millennium Management LLC

$175 Billion
Q1 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Moderna, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 308,700 shares of MRNA stock, worth $7.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

308,700

Previous 306,800 0.62%

Holding current value

$7.92 Million

Previous $12.8 Million 31.4%

% of portfolio

0.0%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$28.35 - $47.53 $27.8 Million - $46.6 Million	-980,074 Reduced 86.82%	148,794 $4.22 Million
Q4 2024 Feb 14, 2025	BUY	$36.85 - $63.93 $36.1 Million - $62.6 Million	978,550 Added 650.99%	1,128,868 $46.9 Million
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $6.44 Million - $12.7 Million	101,120 Added 205.54%	150,318 $10 Million
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $4.73 Million - $7.78 Million	-46,690 Reduced 48.69%	49,198 $5.84 Million
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $2.84 Million - $3.84 Million	33,226 Added 53.02%	95,888 $10.2 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $6.83 Million - $10.3 Million	-98,301 Reduced 61.07%	62,662 $6.23 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $4.96 Million - $6.72 Million	41,872 Added 35.16%	160,963 $19.6 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $3.13 Million - $4.55 Million	-23,098 Reduced 16.24%	119,091 $18.3 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $7.83 Million - $13.9 Million	-66,123 Reduced 31.74%	142,189 $25.5 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $9.4 Million - $15.5 Million	-79,599 Reduced 27.65%	208,312 $24.6 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $18.5 Million - $27.9 Million	158,275 Added 122.09%	287,911 $41.1 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $18.2 Million - $33.9 Million	-144,081 Reduced 52.64%	129,636 $22.3 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $20.2 Million - $32.9 Million	89,389 Added 48.49%	273,717 $69.5 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $52.1 Million - $114 Million	-234,577 Reduced 56.0%	184,328 $70.9 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $44 Million - $79.6 Million	338,679 Added 422.16%	418,905 $98.4 Million
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $52.1 Million - $88.7 Million	-476,983 Reduced 85.6%	80,226 $10.5 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $31.9 Million - $82.4 Million	485,385 Added 675.8%	557,209 $58.2 Million
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $25.9 Million - $45.2 Million	-476,153 Reduced 86.89%	71,824 $5.08 Million
Q2 2020 Aug 14, 2020	SELL	$29.67 - $80.0 $2.03 Million - $5.47 Million	-68,434 Reduced 11.1%	547,977 $35.2 Million
Q1 2020 May 14, 2020	BUY	$17.78 - $31.58 $11 Million - $19.5 Million	616,411 New	616,411 $18.5 Million
Q3 2019 Nov 14, 2019	SELL	$12.26 - $18.07 $1.19 Million - $1.75 Million	-97,027 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$13.7 - $28.34 $936,025 - $1.94 Million	68,323 Added 238.03%	97,027 $1.42 Million
Q1 2019 May 14, 2019	SELL	$14.45 - $23.7 $2.15 Million - $3.52 Million	-148,536 Reduced 83.81%	28,704 $584,000
Q4 2018 Feb 14, 2019	BUY	$13.52 - $18.8 $2.4 Million - $3.33 Million	177,240 New	177,240 $2.71 Million

Others Institutions Holding MRNA

# of Institutions

848

Shares Held

258M

Call Options Held

22.4M

Put Options Held

30.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $10B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account